Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Larimar Therapeutics Inc (NQ: LRMR )

2.150 +0.190 (+9.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45,952
Open 2.020
Bid (Size) 2.030 (2)
Ask (Size) 3.280 (1)
Prev. Close 1.960
Today's Range 2.020 - 2.370
52wk Range 1.900 - 15.26
Shares Outstanding 17,710,450
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday. 
Via Benzinga
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Investor Alert: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 05/02/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Larimar Therapeutics, Inc. 
Via SBWire

Performance

YTD
-80.00%
-80.00%
1 Month
-18.56%
-18.56%
3 Month
-45.43%
-45.43%
6 Month
-80.00%
-80.00%
1 Year
-81.19%
-81.19%

More News

Read More
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Investor Notice: Investigation over Possible Violations of Securities Laws
Via SBWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Larimar Therapeutics, Inc. (LRMR) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Larimar Therapeutics, Inc. (LRMR) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
55 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps 400 Points; Marriott International Tops Q4 Views
Via Benzinga
Mid-Day Market Update: Crude Oil Down 4%; US Producer Prices Rise 1% In January
Via Benzinga
31 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Mid-Morning Market Update: Markets Open Higher On Easing Russia-Ukraine Tensions
Via Benzinga
Futures Soar, Safe Havens Tumble After Russia Announces Some Troops Returning To Base
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2022
Via Benzinga
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
Via Benzinga
Larimar Stock Plunges As FDA Asks For Additional Data To Resolve Clinical Hold On Friedreich's Ataxia Program
Via Benzinga
22 Stocks Moving in Tuesday's Pre-Market Session
Via Benzinga
41 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
42 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
77 Biggest Movers From Yesterday
Via Benzinga
61 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.